Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
China
· Delayed Price · Currency is CNY 9.60
+0.04 (0.42%)
Apr 29, 2026, 3:00 PM CST
SHA:600420 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 9,218 | 10,770 | 11,787 | 12,810 | 13,756 | Upgrade
|
| Other Revenue | 145.01 | 167.77 | 282.98 | 149.79 | 189.06 | Upgrade
|
| Revenue | 9,363 | 10,938 | 12,070 | 12,959 | 13,945 | Upgrade
|
| Revenue Growth (YoY) | -14.39% | -9.38% | -6.86% | -7.07% | 11.06% | Upgrade
|
| Cost of Revenue | 6,438 | 6,822 | 7,538 | 8,091 | 7,909 | Upgrade
|
| Gross Profit | 2,925 | 4,116 | 4,532 | 4,868 | 6,036 | Upgrade
|
| Selling, General & Admin | 1,280 | 1,921 | 2,906 | 3,414 | 4,220 | Upgrade
|
| Research & Development | 437.58 | 565.65 | 562.24 | 517.14 | 584.97 | Upgrade
|
| Other Operating Expenses | 78.12 | 78.88 | 99 | 113.17 | 128.31 | Upgrade
|
| Operating Expenses | 1,812 | 2,563 | 3,549 | 4,027 | 4,958 | Upgrade
|
| Operating Income | 1,114 | 1,553 | 983.4 | 841.24 | 1,078 | Upgrade
|
| Interest Expense | -4.39 | -36.89 | -57.88 | -107.31 | -110.47 | Upgrade
|
| Interest & Investment Income | 177.49 | 151.08 | 136.48 | 61.69 | 48.84 | Upgrade
|
| Currency Exchange Gain (Loss) | 2.29 | 40.61 | 28.44 | 98.32 | -32.65 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.31 | -2.01 | -4.09 | -4.23 | -5.75 | Upgrade
|
| EBT Excluding Unusual Items | 1,287 | 1,705 | 1,086 | 889.71 | 978 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -132.15 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -24.04 | Upgrade
|
| Gain (Loss) on Sale of Assets | -2.65 | -31.31 | -31.85 | -1.1 | 0.2 | Upgrade
|
| Asset Writedown | -32.79 | -28.26 | -13.13 | -4.93 | -10.81 | Upgrade
|
| Other Unusual Items | 76.19 | 27.33 | 55.19 | 100.45 | 107 | Upgrade
|
| Pretax Income | 1,328 | 1,673 | 1,097 | 984.12 | 918.21 | Upgrade
|
| Income Tax Expense | 185.42 | 340.97 | 131.95 | 116.63 | 97.06 | Upgrade
|
| Earnings From Continuing Operations | 1,142 | 1,332 | 964.61 | 867.48 | 821.15 | Upgrade
|
| Minority Interest in Earnings | -200.56 | -248.46 | -272.73 | -239.69 | -252.87 | Upgrade
|
| Net Income | 941.6 | 1,084 | 691.88 | 627.79 | 568.28 | Upgrade
|
| Net Income to Common | 941.6 | 1,084 | 691.88 | 627.79 | 568.28 | Upgrade
|
| Net Income Growth | -13.11% | 56.62% | 10.21% | 10.47% | -12.41% | Upgrade
|
| Shares Outstanding (Basic) | 1,341 | 1,341 | 1,273 | 1,027 | 1,027 | Upgrade
|
| Shares Outstanding (Diluted) | 1,341 | 1,341 | 1,273 | 1,156 | 1,178 | Upgrade
|
| Shares Change (YoY) | - | 5.31% | 10.13% | -1.82% | -0.14% | Upgrade
|
| EPS (Basic) | 0.70 | 0.81 | 0.54 | 0.61 | 0.55 | Upgrade
|
| EPS (Diluted) | 0.70 | 0.81 | 0.54 | 0.54 | 0.48 | Upgrade
|
| EPS Growth | -13.11% | 48.72% | 0.07% | 12.52% | -12.29% | Upgrade
|
| Free Cash Flow | 1,434 | 2,036 | 1,363 | 2,548 | 1,158 | Upgrade
|
| Free Cash Flow Per Share | 1.07 | 1.52 | 1.07 | 2.20 | 0.98 | Upgrade
|
| Dividend Per Share | 0.300 | 0.300 | 0.100 | 0.100 | 0.100 | Upgrade
|
| Dividend Growth | - | 200.00% | - | - | - | Upgrade
|
| Gross Margin | 31.25% | 37.63% | 37.55% | 37.57% | 43.28% | Upgrade
|
| Operating Margin | 11.89% | 14.19% | 8.15% | 6.49% | 7.73% | Upgrade
|
| Profit Margin | 10.06% | 9.91% | 5.73% | 4.84% | 4.08% | Upgrade
|
| Free Cash Flow Margin | 15.32% | 18.62% | 11.29% | 19.66% | 8.31% | Upgrade
|
| EBITDA | 1,812 | 2,325 | 1,802 | 1,671 | 1,857 | Upgrade
|
| EBITDA Margin | 19.36% | 21.25% | 14.93% | 12.90% | 13.31% | Upgrade
|
| D&A For EBITDA | 698.59 | 772.32 | 818.89 | 830.01 | 778.52 | Upgrade
|
| EBIT | 1,114 | 1,553 | 983.4 | 841.24 | 1,078 | Upgrade
|
| EBIT Margin | 11.89% | 14.19% | 8.15% | 6.49% | 7.73% | Upgrade
|
| Effective Tax Rate | 13.97% | 20.38% | 12.03% | 11.85% | 10.57% | Upgrade
|
| Revenue as Reported | 9,363 | 10,938 | 12,070 | 12,959 | 13,945 | Upgrade
|
| Advertising Expenses | 4.69 | 6.18 | 4.64 | 3.29 | 7.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.